SG Americas Securities’s Definium Therapeutics DFTX Stock Holding History

SG Americas Securities’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$198K	Buy	+10,493	New	+$178K	﹤0.01%	2645
2025 Q1	–	Sell	-24,406	Closed	-$170K	–	3635
2024 Q4	$170K	Buy	24,406 +8,004	+49%	+$55.1K	﹤0.01%	2306
2024 Q3	$93K	Buy	+16,402	New	+$114K	﹤0.01%	3100
2022 Q1	–	Sell	-4,143	Closed	-$86K	–	3270
2021 Q4	$86K	Sell	4,143 -5,259	-56%	-$168K	﹤0.01%	3116
2021 Q3	$329K	Buy	9,402 +8,232	+704%	+$356K	﹤0.01%	2859
2021 Q2	$61K	Buy	+1,170	New	+$61.4K	﹤0.01%	2723

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SG Americas Securities's DFTX Position: Q1 2026 in Review

SG Americas Securities opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 10,493 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #2645 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in DFTX as recently as Q4 2024.

SG Americas Securities first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. The position peaked at $329K in Q3 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

SG Americas Securities held 10,493 shares of Definium Therapeutics worth $198K as of Q1 2026.
Definium Therapeutics was a new SG Americas Securities position in Q1 2026.
Definium Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2645 holding.
SG Americas Securities first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
SG Americas Securities's Definium Therapeutics position peaked at $329K in Q3 2021.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.